University of Minnesota Medical School
"The University of Minnesota will be able to leverage decades of experience in basic and translational science in hematology from international leaders in the field to train the next generation of classical hematologists. In addition, our faculty put a premium on advancing health equity in the field, not just within our clinic but at a system level, and we look forward to working with trainees who want to have an impact both in the clinic and within the broader community. Finally, as a lifespan hematologist and one of the few in the nation, I look forward to working directly with trainees who see value in taking on the transition challenges for individuals with chronic hematologic diseases and who will help fill a major gap in clinical care."
Alex Boucher, MD, FAAP, HFFTP Associate Program Director
Contact: [email protected]
"The University of Minnesota has a long-standing history of training clinicians and researchers in non-malignant hematology. We have worked to accommodate the growing interest of trainees by increasing our number of non-malignant hematology faculty and our research portfolio. The ASH HFFTP award will help us to strengthen the opportunities for those trainees committed to academic careers in non-malignant hematology. I am especially excited about our trainees gaining expertise in the management of young adults with life-long hematologic disorders, such as sickle cell disease, porphyria, and hemophilia. Our training in non-malignant hematology will provide trainees with the skills and experiences to truly transform the care of these patients."
Yvonne H. Datta, MD, HFFTP Program Director
Contact: [email protected]
The University of Minnesota has a long history of excellence in bench-to-bedside hematology research and clinical care. Faculty in the Hematology, Oncology, and Transplantation Fellowship Program are excited to expand upon this foundation to train the next generation of hematologists. This program offers rotations at four sites throughout the Minneapolis-St. Paul metropolitan area. Training emphasizes diagnosis and management of hematologic conditions in both the outpatient and inpatient settings. All trainees receive intensive mentoring and exposure to non-malignant disorders, hematologic malignancies, stem cell transplantation, cellular therapies, and hematopathology. Additionally, trainees participate in cutting-edge translational or clinical research, including gene therapy and gene editing trials for hemoglobinopathies and phase 1 trials for innovative therapies.
With the support of the HFFTP award, the University of Minnesota fellowship program now uniquely incorporates into the broad-based core curriculum training in lifespan hematology. Each trainee can choose between one of two lifespan hematology tracks: red cell disorders, cytopenias, and marrow failure syndromes or hemostasis, thrombosis, and vascular medicine. Dr. Alex Boucher, the HFFTP associate program director, is a combined medical and pediatric hematologist, whose mentorship will allow trainees to gain expertise in adolescent and young adult hematology in an immersive experience few programs can match.